Antibody

Wacker Bio licenses its E. coli based production strain to PhaseBio

06-May-2019 By Maggie Lynch

Wacker licenses E. coli based production strain to PhaseBio for the manufacture of antibody fragment.

CDMO collaborates with synthetic DNA provider for biologic drug development

08-Apr-2019 By Maggie Lynch

Twist Bioscience, a synthetic DNA provider, enters a strategic collaboration with LakePharma to bolster antibody discovery and optimization for biologic drug development.

Ligand and Genagon ink drug development agreement

12-Feb-2019 By Maggie Lynch

Ligand Pharmaceuticals enters an agreement with Genagon to provide access to its drug development platform capable of producing fully human antibodies.

Ablexis licenses antibodies for CAR-T development

03-Jan-2019 By Maggie Lynch

The clinical-stage biotechnology company Allogene has licensed Ablexis’ antibodies for the use of CAR-T therapy research and development.

Fusion Antibodies collab using AI to generate humanized antibodies

27-Nov-2018 By Maggie Lynch

Fusion Antibodies signed an agreement with Analytics Engines to bring machine learning and AI to its humanization platform in an aim to bolster product quality and manufacturability.

Update

Charles River teams with Distributed Bio to advance antibody discovery platform

25-Oct-2018 By Melissa Fassbender

Charles River and Distributed Bio are creating an integrated antibody discovery and development platform as part of an exclusive partnership.

Abzena announces licensing agreement for T-cell engineering

24-Sep-2018 By Maggie Lynch

Abzena has signed an antibody humanization agreement with Tmunity Therapeutics a clinical stage T cell therapy company.

Immunoprecise ups antibody services with second CRO purchase

03-Oct-2017 By Melissa Fassbender

Immunoprecise Antibodies is set to purchase QVQ Holding BV in its most recent acquisition that further increases its antibody services.

Cancer-hunting shark proteins are the future of drug conjugation, says Almac

19-May-2015 By Fiona BARRY

Almac is coupling tiny shark proteins to a cancer-killing warhead to develop an oncology drug, saying their small size makes for easy conjugation. 

Celgene and Innovent Select Adimab for Discovery Tech

21-Aug-2013 By Dan Stanton

Adimab says there are more antibody discovery partnerships to come following deals inked with Celgene and Innovent.

Wuxi enters Ab sector in partnership with transgenic rat developer OMT

06-Sep-2012

WuXi PharmaTech has formed an antibody discovery partnership with US transgenic animals firm Open Monoclonal Technology (OMT).

SGS opens assay lab in France

13-Jun-2012 By Gareth Macdonald

SGS’ has opened a new cell-based assay laboratory in Poitiers, France in its latest European, biopharma-focused investment.

Evotec and 4-Antibody team up to "revolutionise" early antibody detection

21-May-2012

Evotec and 4-Antibody have teamed up to offer a new antibody testing service.

Outsourcing brings Neovacs to cusp of Ph III partnership

09-Aug-2011 By Nick Taylor

Neovacs is looking to partner for late stage development after using its outsourced model to bring multiple products to Phase II.

ForteBio unleash Protein G biosensor for Ab drug discovery on Octet instrumentation

08-Sep-2010 By Alexandria Pesic

The life sciences company, ForteBio, has launched its Dip and Read Protein G biosensor, designed for the fast-track analysis of specific biomolecular interactions of various types of the antibody molecule, mammalian immunoglobulin.